The NanoDiaRA project developed a nanoparticle-based system for the detection of osteoarthritis and rheumatoid arthritis, the two most common forms of the disease, which is a leading cause of pain and disability. “Our particles are designed for use as a contrast agent in magnetic resonance imaging [MRI],” says scientific coordinator Dr Margarethe Hofmann of MatSearch Consulting Hofmann in Switzerland.

Read more